rs78781527

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001102401.4(TTI2):​c.118C>T​(p.Pro40Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00708 in 1,614,082 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P40L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0050 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0073 ( 60 hom. )

Consequence

TTI2
NM_001102401.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.628

Publications

8 publications found
Variant links:
Genes affected
TTI2 (HGNC:26262): (TELO2 interacting protein 2) This gene encodes a regulator of the DNA damage response. The protein is a component of the Triple T complex (TTT) which also includes telomere length regulation protein and TELO2 interacting protein 1. The TTT complex is involved in cellular resistance to DNA damage stresses and may act as a regulator of phosphoinositide-3-kinase-related protein kinase (PIKK) abundance. [provided by RefSeq, May 2013]
TTI2 Gene-Disease associations (from GenCC):
  • severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038638413).
BP6
Variant 8-33512496-G-A is Benign according to our data. Variant chr8-33512496-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 437085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00499 (759/152200) while in subpopulation NFE AF = 0.00833 (567/68032). AF 95% confidence interval is 0.00777. There are 1 homozygotes in GnomAd4. There are 325 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 60 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTI2NM_001102401.4 linkc.118C>T p.Pro40Ser missense_variant Exon 2 of 8 ENST00000431156.7 NP_001095871.1 Q6NXR4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTI2ENST00000431156.7 linkc.118C>T p.Pro40Ser missense_variant Exon 2 of 8 1 NM_001102401.4 ENSP00000411169.3 Q6NXR4

Frequencies

GnomAD3 genomes
AF:
0.00498
AC:
758
AN:
152082
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00179
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00446
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00208
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00832
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00472
AC:
1187
AN:
251382
AF XY:
0.00480
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00292
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00240
Gnomad NFE exome
AF:
0.00773
Gnomad OTH exome
AF:
0.00505
GnomAD4 exome
AF:
0.00730
AC:
10668
AN:
1461882
Hom.:
60
Cov.:
34
AF XY:
0.00714
AC XY:
5192
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00128
AC:
43
AN:
33480
American (AMR)
AF:
0.00331
AC:
148
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00597
AC:
156
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00129
AC:
111
AN:
86258
European-Finnish (FIN)
AF:
0.00251
AC:
134
AN:
53420
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.00871
AC:
9690
AN:
1112006
Other (OTH)
AF:
0.00628
AC:
379
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
685
1371
2056
2742
3427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00499
AC:
759
AN:
152200
Hom.:
1
Cov.:
31
AF XY:
0.00437
AC XY:
325
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00178
AC:
74
AN:
41506
American (AMR)
AF:
0.00445
AC:
68
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4830
European-Finnish (FIN)
AF:
0.00208
AC:
22
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00833
AC:
567
AN:
68032
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00696
Hom.:
6
Bravo
AF:
0.00522
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.0109
AC:
42
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00930
AC:
80
ExAC
AF:
0.00498
AC:
605
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00725
EpiControl
AF:
0.00717

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTI2: BP4, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 16, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
11
DANN
Benign
0.95
DEOGEN2
Benign
0.0078
T;T;T;.;T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.74
T;.;.;T;T
MetaRNN
Benign
0.0039
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;L;L;.;.
PhyloP100
0.63
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.38
.;N;N;N;D
REVEL
Benign
0.063
Sift
Benign
0.34
.;T;T;T;T
Sift4G
Benign
0.18
T;T;T;T;T
Polyphen
0.035
B;B;B;B;.
Vest4
0.076
MVP
0.33
MPC
0.15
ClinPred
0.0094
T
GERP RS
4.4
PromoterAI
0.0038
Neutral
Varity_R
0.050
gMVP
0.079
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78781527; hg19: chr8-33370014; COSMIC: COSV100659573; COSMIC: COSV100659573; API